fda approval in lung cancer, promising findings in hodgkin lymphoma, and more
Published 7 years ago • 242 plays • Length 9:42
Download video MP4
Download video MP3
Similar videos
-
9:10
fda approvals in cml and hodgkin lymphoma, priority review in crc, and more
-
10:18
fda approvals in bladder cancer and hodgkin lymphoma, breakthrough designation in aml, and more
-
7:39
fda approvals in follicular lymphoma and gi, lung nets, snda in prostate cancer, and more
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
6:09
fda approvals in breast cancer and hodgkin lymphoma, 2017 sgo highlights, and more
-
9:25
fda approvals in large b-cell lymphoma and melanoma, priority reviews in cscc and nsclc, and more
-
13:02
fda approvals in non-hodgkin lymphoma, breast cancer, gvhd, and mesothelioma
-
1:06
the difference between hodgkin's and non-hodgkin's lymphoma cancers explained in 60 seconds
-
7:26
fda approval in ovarian cancer, priority reviews in nsclc, cll, and follicular lymphoma, and more
-
13:36
fda approval in prostate cancer, nda submitted in cll and follicular lymphoma, and more
-
7:40
clinical hold in all study, fda draft guidelines, expanded approval in hodgkin lymphoma
-
9:41
fda approvals in follicular lymphoma and prostate cancer, biosimilar is granted approval, and more
-
8:01
fda activity for nivolumab, t-vec in melanoma, new lung cancer findings, mds findings, and more
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
7:18
full fda approvals in breast cancer and lung cancer, priority reviews in all, and more
-
0:28
dr. straus on fda approval of pembrolizumab in hodgkin lymphoma
-
0:31
preview: fda approval in nsclc and ema regulatory advances
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
7:07
fda approval in crc, priority review in hcc, encouraging data in myeloma trial, and more
Clip.africa.com - Privacy-policy